# Treatment holidays in patients with Erdheim-Chester disease receiving vemurafenib: a prospective pilot study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/treatment-holidays-in-patients-with-erdheim-chester-disease-receiving/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Francesco Pegoraro,Francesco Catamerò,Federica Allegretta,Giulia Palazzini,Francesco Peyronel,Eli L. Diamond,Augusto Vaglio |
| Citations | 9 |
| DOI | 10.1182/bloodadvances.2024015399 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://doi.org/10.1182/bloodadvances.2024015399 |
| OpenAlex ID | https://openalex.org/W4406203365 |
| PMID | 39787607 |
| Type | article |
| Year | 2025 |

## Paper authors

- [Augusto Vaglio](https://scholariq.org/researchers/augusto-vaglio/)

## Paper journal

- [Blood Advances](https://scholariq.org/journals/blood-advances/)

## Paper primary topic

- [Histiocytic Disorders and Treatments](https://scholariq.org/topics/histiocytic-disorders-and-treatments/)

## Paper topics

- [Histiocytic Disorders and Treatments](https://scholariq.org/topics/histiocytic-disorders-and-treatments/)
- [Myeloproliferative Neoplasms: Diagnosis and Treatment](https://scholariq.org/topics/myeloproliferative-neoplasms-diagnosis-and-treatment/)
- [Genital Health and Disease](https://scholariq.org/topics/genital-health-and-disease/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.